Coeptis Therapeutics Holdings, Inc.
COEP
Revenue
62.87k
▲62.87k∞%
6 Months ChangeAssets
13.45M
▲4.54M▲51.01%
3 Months ChangeLiabilities
5.99M
▲948.72k▲18.82%
3 Months ChangeFree Cash Flow
-1.68M
▼-722.74k▼-75.15%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-09-30
Form 8-K
ID: 0001683168-24-006763
2024-09-19
Form 8-K
ID: 0001683168-24-006521
2024-08-16
Form 10-Q
ID: 0001683168-24-005799
2024-08-14
Form 8-K
ID: 0001683168-24-005713
2024-07-31
Form 8-K
ID: 0001683168-24-005183
2024-06-20
Form 8-K
ID: 0001683168-24-004361
2024-05-10
Form 10-Q
ID: 0001683168-24-003228
2024-03-25
Form 8-K
ID: 0001683168-24-001672
2024-02-01
Form 8-K
ID: 0001683168-24-000615
2023-12-22
Form 8-K
ID: 0001683168-23-009058